1999
Complications and Expected Outcome of Glioma Surgery
Vives K, Piepmeier J. Complications and Expected Outcome of Glioma Surgery. Journal Of Neuro-Oncology 1999, 42: 289-302. PMID: 10433111, DOI: 10.1023/a:1006163328765.Peer-Reviewed Original ResearchConceptsSurgical resectionKarnofsky performance statusGross total resectionManagement of patientsRisk of complicationsUse of radiotherapyRisk of recurrenceHigh-grade lesionsMaximum safe resectionCareful preoperative planningHigh-grade gliomasLow-grade gliomasPerformance statusExtensive surgeryMajor complicationsProlong survivalTotal resectionNeurologic impairmentGrade lesionsSafe resectionTreatment modalitiesIntraoperative mappingGlioma surgeryIntracerebral gliomasSurvival advantage
1996
A phase III randomized prospective trial of external beam radiotherapy, mitomycin C, carmustine, and 6-mercaptopurine for the treatment of adults with anaplastic glioma of the brain
Halperin E, Herndon J, Schold S, Brown M, Vick N, Cairncross J, Macdonald D, Gaspar L, Fischer B, Dropcho E, Rosenfeld S, Morowitz R, Piepmeier J, Hait W, Byrne T, Salter M, Imperato J, Khandekar J, Paleologos N, Burger P, Bentel G, Friedman A. A phase III randomized prospective trial of external beam radiotherapy, mitomycin C, carmustine, and 6-mercaptopurine for the treatment of adults with anaplastic glioma of the brain. International Journal Of Radiation Oncology • Biology • Physics 1996, 34: 793-802. PMID: 8598355, DOI: 10.1016/0360-3016(95)02025-x.Peer-Reviewed Original ResearchConceptsExternal beam radiotherapyKarnofsky performance statusMedian survivalSurvival benefitERT groupAnaplastic gliomasBeam radiotherapyMitomycin CVs. 11.4 monthsProportion of patientsSignificant survival benefitPossible survival benefitTreatment of adultsYears of ageBCNU groupPerformance statusProspective trialHistologic diagnosisMalignant gliomasMito groupStereotactic biopsyPatientsGreater riskFourth weekThird day